Showing results (481-490 of 573) with videos related to
Sort By:
Pageof 58
Journal of Bodywork and Movement Therapies|March 14, 2021
Effect of two Dynamic Tape™ applications on the electromyographic activity of the gluteus medius and functional performance in women: A randomized, controlled, clinical trialRoberta O Silva, Filipe R Carlos, Melina C Morales, et al.Leukemia & Lymphoma|January 15, 2013
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical studyBenjamin M Cherry, Neha Korde, Mary Kwok, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.Operative Dentistry|December 20, 2021
Impact of Resin Composite Viscosity and Fill-technique on Internal Gap in Class I Restorations: An OCT EvaluationK R Kantovitz, L L Cabral, N R Carlos, et al.Blood Advances|April 25, 2020
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopeniasXing Fan, Ronan Desmond, Thomas Winkler, et al.The New England Journal of Medicine|January 10, 2019
Plerixafor for the Treatment of WHIM SyndromeDavid H McDermott, Diana V Pastrana, Katherine R Calvo, et al.Bioorganic & Medicinal Chemistry Letters|April 8, 2006
Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug designDaniel J Parks, Louis V LaFrance, Raul R Calvo, et al.Science Advances|July 9, 2025
Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AMLGege Gui, Molly A Bingham, Julius R Herzog, et al.Cytokine|July 22, 2014
Altered cytokine and chemokine profiles in multiple myeloma and its precursor diseaseAdriana Zingone, Weixin Wang, Meghan Corrigan-Cummins, et al.American Journal of Hematology|December 15, 2015
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)Clive S Zent, Xin Victoria Wang, Rhett P Ketterling, et al.Pageof 58